REV Venture Partners

RELX is a global provider of data-driven analytics and decision tools across diverse industries such as science, law, healthcare, and business. With headquarters in London, RELX operates in over 40 countries, serving millions of professionals worldwide through subsidiaries like Elsevier, LexisNexis, and Reed Exhibitions. These platforms offer critical insights, from scientific research and legal frameworks to business intelligence, aiding decision-making for customers in more than 180 countries​. In addition to its core services, RELX has a venture capital arm called REV, which invests in early-stage companies that are reshaping industries through innovative uses of data and technology. Since its founding in 2000, REV has allocated over $250 million across a range of sectors, particularly artificial intelligence, data science, and healthcare technology. The firm’s portfolio boasts numerous successful exits, including Palantir’s IPO and acquisitions by leading firms such as HealthQuest Capital, Edifecs, and IBM. REV’s mission is to foster companies that can scale transformative technologies globally, helping to solve complex problems in areas such as healthcare, legal tech, and digital content management​. Through these investments, RELX combines its expertise in data analytics with a strategic approach to innovation, enabling it to remain at the forefront of digital transformation across industries. This dual focus on operational excellence and forward-thinking investments positions RELX as a key player in both traditional and emerging markets.